Syndax
Chris Janssen is currently the Vice President of Financial Planning & Analysis at Syndax Pharmaceuticals. With extensive experience in various financial roles in the pharmaceutical and healthcare industries, Chris has held positions such as Sr. Director at Idorsia Pharmaceuticals US Inc., Vice President at Optinose, and Director of Financial Planning and Analysis at Compass One Healthcare. With a background in accounting and finance, Chris has been instrumental in financial planning activities, budgeting, and providing financial guidance for decision-making throughout their career.
This person is not in any offices
Syndax
Syndax Pharmaceuticals, Inc (Syndax) is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The Company’s product candidate, entinostat, which was granted Breakthrough The...